Lisata Therapeutics, Inc. (LSTA)
1.935
+0.08
(+4.03%)
USD |
NASDAQ |
Sep 09, 12:39
Lisata Therapeutics Price to Book Value : 2.140 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.057 |
| September 04, 2026 | 1.825 |
| September 03, 2026 | 1.814 |
| September 02, 2026 | 1.737 |
| September 01, 2026 | 1.737 |
| August 31, 2026 | 1.648 |
| August 28, 2026 | 1.869 |
| August 27, 2026 | 2.013 |
| August 26, 2026 | 2.002 |
| August 25, 2026 | 1.925 |
| August 24, 2026 | 1.947 |
| August 21, 2026 | 1.714 |
| August 20, 2026 | 1.239 |
| August 19, 2026 | 1.239 |
| August 18, 2026 | 1.272 |
| August 17, 2026 | 1.195 |
| August 14, 2026 | 1.206 |
| August 13, 2026 | 1.250 |
| August 12, 2026 | 1.305 |
| August 11, 2026 | 1.338 |
| August 10, 2026 | 1.206 |
| August 07, 2026 | 1.172 |
| August 06, 2026 | 1.184 |
| August 05, 2026 | 1.239 |
| August 04, 2026 | 1.261 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.150 |
| July 31, 2026 | 1.095 |
| July 30, 2026 | 1.139 |
| July 29, 2026 | 1.206 |
| July 28, 2026 | 1.283 |
| July 27, 2026 | 1.593 |
| July 24, 2026 | 1.847 |
| July 23, 2026 | 2.345 |
| July 22, 2026 | 2.434 |
| July 21, 2026 | 2.478 |
| July 20, 2026 | 3.899 |
| July 17, 2026 | 3.977 |
| July 16, 2026 | 3.872 |
| July 15, 2026 | 4.148 |
| July 14, 2026 | 4.104 |
| July 13, 2026 | 4.093 |
| July 10, 2026 | 3.617 |
| July 09, 2026 | 3.578 |
| July 08, 2026 | 3.551 |
| July 07, 2026 | 3.617 |
| July 06, 2026 | 3.706 |
| July 02, 2026 | 3.683 |
| July 01, 2026 | 3.717 |
| June 30, 2026 | 3.761 |
| June 29, 2026 | 2.826 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.653 |
| Alnylam Pharmaceuticals, Inc. | 25.25 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.692 |
| Vericel Corp. | 5.368 |
Price to Book Value Related Metrics
| PS Ratio | 172.62 |
| Price | 1.935 |
| Earnings Yield | -84.80% |
| Market Cap | 17.65M |